In the bestselling tradition of Jeffrey Archer and Dick Francis comes a hot new commercial talent.
A young scientist, Cameron, has an idea which could revolutionise medicine. She believes that, once published, her findings will change the world.
A maverick financier, Bryn, sees the potential, but convinces her that truth alone is never what secures change: it's money, nous and competitive savvy.
He persuades her to go into business with him. Their aim: to build a stockmarket company worth a hundred million pounds - big enough to survive assault; strong enough to market Cameron's technology to the entire world.
Corinth, a corporation worth a hundred billion dollars, sees Cameron's technology as a threat and aims to wipe out the fledgling enterprise.
The story becomes a race to the stockmarket - and a battle to survive.
ISBN: | 9780006513551 |
Publication date: | 2nd April 2001 |
Author: | Harry Bingham |
Publisher: | HarperCollinsPublishers an imprint of HarperCollins Publishers |
Format: | Paperback |
Pagination: | 436 pages |
Genres: |
Modern and Contemporary Fiction Technothriller Medical thriller Narrative theme: Health and illness Narrative theme: Social issues Finance and the finance industry |